Drawing for TF IMMUNE SPRAY

USPTO serial 76373142

TF IMMUNE SPRAY

Reviewed by CopyMark Law Group

Reg. 2679210Status 710
Filing date
Status date
Registration date
Jan 21, 2003
Examiner
EDWARDS, ALICIA COLLINS
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TF IMMUNE SPRAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Glenn Spencer Bacal

Glenn Spencer Bacal Holme Roberts & Owen LLP16427 North Scottsdale Road, Suite 300Scottsdale, AZ 85254-1597UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005DIETARY SUPPLEMENTS, VITAMINS, MINERAL SUPPLEMENTS, HERBAL SUPPLEMENTS AND NUTRITIONAL SPRAY PREPARATIONS FOR NOSE AND THROAT CONTAINING IMMUNE FACTORS DERIVED FROM COLOSTRUMSECTION 8 - CANCELLEDFeb 15, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 3, 2010ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 29, 2009C8..CANCELLED SEC. 8 (6-YR)—
Jul 28, 2008CFITCASE FILE IN TICRS—
May 15, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 12, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Jul 8, 2005MAILPAPER RECEIVED—
Apr 23, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 22, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 5, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 21, 2003R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Nov 16, 2002CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Oct 21, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2002MAILPAPER RECEIVED—
Sep 25, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 5, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 5, 2002MAILPAPER RECEIVED—
Jul 5, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2002DOCKASSIGNED TO EXAMINER—
Jun 12, 2002DOCKASSIGNED TO EXAMINER—
Jun 12, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance